(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-KLRG1

Em ExigênciaInvention PatentPCT · US2019050110

Application data

Number

112021004553

Type

Invention Patent

Filing

09/06/2019

Publication

06/08/2021

PCT

US2019050110

Progress at the INPI

Technical opinion to answer
  1. Filing09/06/19
  2. Publication06/08/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/03/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ABCURO, INC.

US

THE BRIGHAM AND WOMEN´S HOSPITAL, INC.

US

Inventors

K. T. (pessoa física)

US

S. G. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/732,329 · 09/17/2018

Abstract

A presente invenção refere-se a anticorpos, ou fragmentos de ligação ao antígeno dos mesmos, que se ligam especificamente ao receptor do tipo lectina de célula assassina G1 (KLRG1). Esses anticorpos, ou seus fragmentos de ligação ao antígeno, são úteis para vários fins terapêuticos ou de diagnóstico, incluindo o tratamento de cânceres e para aumentar a eficácia de vacinas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

03/03/2026

RPI 2878

Transferência deferida

#25.1

06/03/2025

RPI 2839

Alteração de sede deferida

#25.7

05/13/2025

RPI 2836

Notificação de entrada na fase nacional - PCT

#1.3

06/08/2021

RPI 2631

Alteração de dados cadastrais

#1.1

03/23/2021

RPI 2620

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.